Institutional Ownership Syndax Pharmaceuticals Inc (SNDX)
This table provides information about the institutional ownership of Syndax Pharmaceuticals Inc (SNDX). We have compiled data on the 254 institutions that hold shares in the stock, with a total of 99.9 Million shares, which have been reported (via 13F filing form) to have a value of $1.66 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2025 Q3 2025 |
8,520,000
shares
|
$142 Million
11.08% of portfolio
|
Q4 2024
Added 45.82%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,906,765
shares
|
$131 Million
0.0% of portfolio
|
Q2 2024
Added 4.69%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
5,486,434
shares
|
$91.2 Million
0.01% of portfolio
|
Q3 2025
Reduced 5.36%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
5,138,617
shares
|
$85.4 Million
0.0% of portfolio
|
Q3 2025
Added 2.08%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2025 Q3 2025 |
4,255,047
shares
|
$70.7 Million
0.13% of portfolio
|
Q3 2025
Added 100.01%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
3,853,549
shares
|
$64 Million
0.0% of portfolio
|
Q3 2025
Added 11.93%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
3,697,753
shares
|
$61.5 Million
0.0% of portfolio
|
Q3 2025
Reduced 3.68%
|
|
|
Eversept Partners, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
3,467,314
shares
|
$57.6 Million
4.13% of portfolio
|
Q3 2025
Reduced 14.71%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
3,311,963
shares
|
$55 Million
0.09% of portfolio
|
Q3 2025
Added 131.21%
|
|
|
Kingdon Capital Management, L.L.C.
New York, NY |
Nov 14, 2025 Q3 2025 |
2,500,000
shares
|
$41.6 Million
5.72% of portfolio
|
Q3 2025
Added 19.05%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
2,390,561
shares
|
$39.7 Million
0.01% of portfolio
|
Q3 2025
Added 1.31%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
2,091,331
shares
|
$34.8 Million
0.0% of portfolio
|
Q3 2025
Added 2.05%
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
2,012,110
shares
|
$33.4 Million
1.88% of portfolio
|
Q3 2025
Added 84.24%
|
|
|
Assenagon Asset Management S.A.
|
Oct 07, 2025 Q3 2025 |
1,784,139
shares
|
$29.7 Million
0.04% of portfolio
|
Q3 2025
Reduced 12.54%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
1,674,513
shares
|
$27.8 Million
0.0% of portfolio
|
Q3 2025
Added 16.66%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
1,644,844
shares
|
$27.3 Million
0.03% of portfolio
|
Q3 2025
Reduced 1.26%
|
|
|
Catalio Capital Management, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,614,717
shares
|
$26.8 Million
4.59% of portfolio
|
Q3 2025
Reduced 23.27%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
1,550,520
shares
|
$25.8 Million
0.12% of portfolio
|
Q3 2025
Reduced 18.08%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
1,475,798
shares
|
$24.5 Million
0.01% of portfolio
|
Q3 2025
Added 454.72%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 14, 2025 Q3 2025 |
1,375,674
shares
|
$22.9 Million
3.83% of portfolio
|
Q3 2025
New holding
|
|
|
Stem Point Capital LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,366,205
shares
|
$22.7 Million
4.21% of portfolio
|
Q3 2025
Reduced 42.42%
|
|
|
Aisling Capital Management LP
New York, NY |
Nov 12, 2025 Q3 2025 |
1,316,806
shares
|
$21.9 Million
4.58% of portfolio
|
Q2 2025
Added 28.47%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Nov 07, 2025 Q3 2025 |
1,236,077
shares
|
$20.5 Million
0.05% of portfolio
|
Q3 2025
Reduced 14.48%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
1,199,296
shares
|
$19.9 Million
0.0% of portfolio
|
Q3 2025
Added 41.22%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
1,077,585
shares
|
$17.9 Million
0.01% of portfolio
|
Q3 2025
Added 67.19%
|
|